insights_auto
Why is ALMKT down ၂.၇၉%?
Dive Deeperchevron_right
ALMKT:EPA
Mauna Kea Technologies SA
၀.၀၈၇ €
arrow_downward
-၂.၇၉%(-၀.၀၀၂၅) 1D
နို ၂၀, GMT+၁ ၁၇:၃၅:၁၁ · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ALMKT...
Open
၀.၀၉ €
High
၀.၀၉ €
Low
၀.၀၉ €
Mkt. cap
၁.၆၇ ကုဋေ
Avg. vol.
၄.၀၇ သိန်း
Volume
၂.၅၉ သိန်း
P/E ratio
၀.၇၄
52-wk high
၀.၂၃ €
52-wk low
၀.၀၇ €
EPS
၀.၁၂ €
Shares outstanding
၁၉.၅၃ ကုဋေ
No. of employees
၅၆
Open
၀.၀၉ €
High
၀.၀၉ €
Low
၀.၀၉ €
Mkt. cap
၁.၆၇ ကုဋေ
Avg. vol.
၄.၀၇ သိန်း
Volume
၂.၅၉ သိန်း
P/E ratio
၀.၇၄
52-wk high
၀.၂၃ €
52-wk low
၀.၀၇ €
EPS
၀.၁၂ €
Shares outstanding
၁၉.၅၃ ကုဋေ
No. of employees
၅၆
News stories
From web sources and news partners
TradingView
·
ပြီးခဲ့သည့် ၁ နာရီ
Ed Yardeni Says Investors Are Overreacting to S&P 500 Selloff
Nacionale
·
ပြီးခဲ့သည့် ၆ နာရီ
Is the S&P 500 in a bear market, and will it rally? No, it's in a correction, 11.6% below its record
Yahoo Finance
·
ပြီးခဲ့သည့် ၃ နာရီ
In the Last Tech Bust, the S&P 500 Lost Money for a Decade. History Says Stocks With the Highest Yields Gained 5.4% a Year.
Beinsure
·
ပြီးခဲ့သည့် ၈ နာရီ
Vanguard S&P 500 ETF: How investing in VOO could build a $1 mn portfolio
Profile
Mauna Kea Technologies is a global medical device company focused on endomicroscopy, the field of microscopic imaging during endoscopy procedures. The company researches, develops and markets tools to visualize, detect, and rule out abnormalities including malignant and pre-malignant tumors or lesions in the gastrointestinal and pulmonary tracts.
The company makes Cellvizio, a probe-based Confocal Laser Endomicroscopy system, which provides physicians and researchers with real-time access to histological information during standard endoscopy procedures through high-resolution cellular imaging of internal tissues.
Cellvizio is used in medical applications such as gastrointestinal endoscopy, pulmonology and urology to help physicians diagnose lesions and make accurate treatment decisions in real-time.
Cellvizio went public in July 2011 and trades on the Euronext Paris exchange. Wikipedia
About Mauna Kea Technologies SA
CEOSacha Loiseau
Employees၅၆
Founded၂၀၀၀
Headquarters-
SectorHealth Care
Industry-
Websitemaunakeatech.com